Which sedative is kinder to the aging brain after surgery?
NCT ID NCT07113483
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two sedative drugs, remimazolam and midazolam, in adults aged 65 and older having orthopedic surgery with regional anesthesia. The goal is to see which drug provides better sedation during surgery and causes fewer problems with thinking and memory shortly after. 120 participants will be randomly assigned to one of the two drugs, and neither they nor their doctors will know which one they received. The results will help doctors choose the safest sedative for older patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP FRACTURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Emergency Hospital of Bucharest
RECRUITINGBucharest, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple pain block might shield aging hearts during hip surgery
- Could a simple ultrasound and nutrition score forecast hip fracture recovery?
- A cheap blood marker might flag delirium risk in elderly surgery patients
- Predicting the unpredictable: can pain, sleep, and brain data forecast surgery risks in seniors?
- Can a simple switch in how acetaminophen is given prevent delirium after hip surgery?
- Spotting the vulnerable: a risk score for post-surgery brain fog in the elderly